Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The first doses of the Oxford-AstraZeneca COVID-19 vaccine were produced at the Clinical BioManufacturing Facility.

These first doses enabled trials to begin in April 2020. You can read the full details of the efforts to manufacture this first batch on the CBF website